Pharmacogenetic Information in Clinical Guidelines: The European Perspective-Reference-Cited by-同舟云学术

Pharmacogenetic Information in Clinical Guidelines: The European Perspective

Published:2018-03-30 Issue:5 Volume:103 Page:795-801
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Swen Jesse J.¹²,Nijenhuis Marga³,van Rhenen Mandy³,de Boer-Veger Nienke J.⁴,Buunk Anne-Marie⁵,Houwink Elisa J.F.⁶,Mulder Hans⁷,Rongen Gerard A.⁸⁹,van Schaik Ron H.N.¹⁰,van der Weide Jan¹¹,Wilffert Bob¹²,Deneer Vera H.M.¹³,Guchelaar Henk-Jan¹²,

Affiliation:

1. Department of Clinical Pharmacy & Toxicology; Leiden University Medical Centre; Leiden The Netherlands

2. Leiden Network for Personalised Therapeutics; Leiden University Medical Centre; Leiden The Netherlands

3. Royal Dutch Pharmacists Association (KNMP), The Hague; The Netherlands

4. Pharmacy Boterdiep; Groningen The Netherlands

5. Pharmacy De Katwijkse Apotheek; Katwijk The Netherlands

6. Department of Public Health and Primary Care (PHEG); Leiden University Medical Center; Leiden The Netherlands

7. Department of Clinical Pharmacy; Wilhelmina Hospital; Assen The Netherlands

8. Department of Internal Medicine; Radboud University Medical Centre; Nijmegen The Netherlands

9. Department of Pharmacology and Toxicology; Radboud University Medical Centre; Nijmegen The Netherlands

10. Department of Clinical Chemistry; Erasmus Medical Center; Rotterdam The Netherlands

11. Department of Clinical Chemistry; St. Jansdal Hospital; Harderwijk The Netherlands

12. Department of PharmacoTherapy, Epidemiology & Economics, Groningen Research Institute of Pharmacy; University of Groningen, Groningen and Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Centre Groningen; Groningen The Netherlands

13. Department of Clinical Pharmacy; University Medical Centre Utrecht; Utrecht The Netherlands

Funder

Horizon 2020 Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference41 articles.

1. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey;Stanek;Clin. Pharmacol. Ther,2012

2. A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations;Bank;Pharmacogenomics,2017

3. An evaluation of pharmacists' expectations towards pharmacogenomics;Denus;Pharmacogenomics,2013

4. Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19;Swen;Eur. J. Clin. Pharmacol,2012

5. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network;Relling;Clin. Pharmacol. Ther,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs;2023-11-08

2. Influence of pharmacogenetics on the diversity of response to statins associated with adverse drug reactions;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-10-11

3. Influencia de la farmacogenética en la diversidad de respuesta a las estatinas asociada a las reacciones adversas;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-10-05

4. Exploring the Attitudes, Beliefs and Perceptions of Undergraduate and Graduate Students in Bangladesh towards Precision Medicine and Pharmacogenomics Practice: A Qualitative Study;European Journal of Medical and Health Sciences;2023-04-29

5. The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients;Pharmacy;2023-04-04